Axonal.AI distinguishes itself from the current wave of generative AI chatbots by positioning itself as an enterprise-native operating layer. While standard LLMs often hallucinate or prioritize ...
Pharma marketers enter 2026 asking where DTC fits in the DTP era. | Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast ...
The state of pharma’s chief marketing officers part 2: Being an ‘innovation catalyst’ for creativity
In the not too distant past, pharma lagged behind consumer advertising’s ability to churn out cutting-edge creativity. Weighed down by the regulatory, safety and compliance aspects that are par for ...
Kal Patel, M.D., is CEO and cofounder of BrightInsight. He has over 20 years of experience in pharma, medtech and regulated digital health. In recent conversations I’ve had with senior pharma leaders, ...
Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of the population, the increased prevalence of chronic disease and the growing ...
Late last year, Pacira hosted an event at the Color Factory interactive art museum in New York City aimed at educating ...
The digital marketing landscape is rapidly changing, as is the creative use of tools and mediums required for successful digital marketing campaigns. This is particularly true in the heavily regulated ...
Innovation in the pharmaceutical industry is changing the landscape of healthcare, leading to incredible treatments that are improving the quality of people’s lives. But pharma marketing strategies ...
Morning Hubsters. John R Fischer here with the US Wire from the New York newsroom. Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of ...
In the ever-evolving landscape of the pharmaceutical industry, marketers are navigating a myriad of challenges and opportunities. The year 2023 marked a period of notable innovations and ...
REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results